Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Sarita Rani Jaiswal"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 5, Pp EC15-EC18 (2022)
Introduction: Diffuse Large B-cell Lymphoma (DLBCL) is the most common type of Non-Hodgkin Lymphoma (NHL) and is categorised into the Germinal Centre B-cell (GCB) and Activated B-cell (ABC/Non GCB) subtypes as per the Cell Of Origin (COO) model with
Externí odkaz:
https://doaj.org/article/1b6c7802221d433c98e6f49ef82b6385
Autor:
Sarita Rani Jaiswal, Jaganath Arunachalam, Ashraf Saifullah, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, Bakulesh Khamar, Sanjay V. Malhotra, Suparno Chakrabarti
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The kinetics of NKG2C+ adaptive natural killer (ANK) cells and NKG2A+inhibitory NK (iNK) cells with respect to the incidence of SARS-CoV-2 infection were studied for 6 months in a cohort of healthcare workers following the administration of the heat-
Externí odkaz:
https://doaj.org/article/d87b5e5b06364190ae7b4af8f61af174
Autor:
Sarita Rani Jaiswal, Ashraf Saifullah, Jaganath Arunachalam, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, Subhrajit Biswas, Bakulesh Khamar, Sanjay V. Malhotra, Suparno Chakrabarti
Publikováno v:
Vaccines, Vol 11, Iss 2, p 328 (2023)
Mycobacterium-w (Mw) was shown to boost adaptive natural killer (ANK) cells and protect against COVID-19 during the first wave of the pandemic. As a follow-up of the trial, 50 healthcare workers (HCW) who had received Mw in September 2020 and subsequ
Externí odkaz:
https://doaj.org/article/862f2163e9b04ac0acd6cdb0f2c50d4d
Autor:
Gitali Bhagawati, Sania Paul, Sarita Rani Jaiswal, Ashutosh Bhardwaj, Rekha Saji Kumar, Mansi, Anita Bhatia, Suparno Chakrabarti
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 3, Pp DC01-DC05 (2022)
Introduction: The Coronavirus Disease-2019 (COVID-19) is associated with damage of cells of both innate and adaptive immunity, which results in immune system’s impairment leading to secondary infections. Microbiological evaluation helps in diagnost
Externí odkaz:
https://doaj.org/article/26f46e147dd44f93a88a48163955b07f
Autor:
Sarita Rani Jaiswal, Jaganath Arunachalam, Ashutosh Bhardwaj, Ashraf Saifullah, Rohit Lakhchaura, Mayank Soni, Gitali Bhagawati, Suparno Chakrabarti
Publikováno v:
Clinical & Translational Immunology, Vol 11, Iss 1, Pp n/a-n/a (2022)
Abstract Objective SARS‐CoV‐2 infection results in severe lung disease in up to 50% of hospitalised patients. The aetiopathogenesis in a subset of such patients, who continue to have progressive pulmonary disease following virus clearance, remain
Externí odkaz:
https://doaj.org/article/9bdbeaa104384913a301abe783a83b48
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 12, Iss 1 (2020)
Externí odkaz:
https://doaj.org/article/270bf6d5141d4d1ca9309bccb9fb1322
Publikováno v:
Indian Journal of Dermatology, Vol 60, Iss 6, Pp 588-591 (2015)
Background: Sirolimus has provided the option for calcineurin inhibitor (CNI)-free immunosuppressive therapy in both solid organ transplant (SOT) and hematopoietic stem cell transplantation (HSCT). However, long-term use of sirolimus has been reporte
Externí odkaz:
https://doaj.org/article/fe4b264382724616a64f60629646ccce
Publikováno v:
Advances in Hematology, Vol 2016 (2016)
Allogeneic hematopoietic stem cell transplantation (HSCT) remains a curative option for children with high risk and advanced acute leukemia. Yet availability of matched family donor limits its use and although matched unrelated donor or mismatched um
Externí odkaz:
https://doaj.org/article/2fd46fa3e4c54476b435ecc76c1864e5
Autor:
Sarita Rani Jaiswal, Ashraf Saifullah, Jaganath Arunachalam, Rohit Lakhchaura, Mahak Agarwal, Prakash Baligar, Subhrajit Biswas, Suparno Chakrabarti
Publikováno v:
Transplantation and Cellular Therapy. 29:S415-S417
Autor:
Sarita Rani Jaiswal, Ashraf Saifullah, Jaganath Arunachalam, Rohit Lakhchaura, Dhanir Tailor, Anupama Mehta, Gitali Bhagawati, Hemamalini Aiyer, Subhrajit Biswas, Bakulesh Khamar, Sanjay V. Malhotra, Suparno Chakrabarti
SUMMARYMycobacterium-w (Mw), was shown to boost adaptive natural killer (ANK) cells and protect against COVID-19 during the first wave of the pandemic. As a follow-up of the trial, 50 healthcare workers (HCW) who had received Mw in September 2020 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80f35cb6da9027a7f553c2ae52794618
https://doi.org/10.1101/2022.11.02.22281822
https://doi.org/10.1101/2022.11.02.22281822